Identifying viable regulatory and innovation pathways for regenerative medicine: a case study of cultured red blood cells. (2015)

First Author: Mittra J
Attributed to:  ESRC Centre for Social and Economic Research on Innovation in Genomics (Innogen) funded by ESRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.nbt.2014.07.008

PubMed Identifier: 25094050

Publication URI: http://europepmc.org/abstract/MED/25094050

Type: Journal Article/Review

Volume: 32

Parent Publication: New biotechnology

Issue: 1

ISSN: 1871-6784